Literature DB >> 26448403

Inhaled Loxapine for Acute Treatment of Agitation in Patients With Borderline Personality Disorder: A Case Series.

Kai G Kahl1, Philip Negt, Axel Wollmer, Stefanie Jung, Tillmann H C Kruger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26448403     DOI： 10.1097/JCP.0000000000000402

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  4 in total

1.  Inhaled Loxapine for Agitation in Intoxicated Patients: A Case Series.

Authors:  Carlos Roncero; Elena Ros-Cucurull; Raúl Felipe Palma-Álvarez; Alfonso Carlos Abad; Christian Fadeuilhe; Miquel Casas; Lara Grau-López
Journal:  Clin Neuropharmacol       Date:  2017 Nov/Dec       Impact factor: 1.592

2.  Inhaled Loxapine for the Treatment of Psychiatric Agitation in the Prehospital Setting: A Case Series.

Authors:  Armando Cester-Martínez; José A Cortés-Ramas; Diego Borraz-Clares; Marta Pellicer-Gayarre
Journal:  Clin Pract Cases Emerg Med       Date:  2017-10-06

3.  Inhaled Loxapine as a Rapid Treatment for Agitation in Patients with Personality Disorder: A Prospective Study on the Effects of Time.

Authors:  Marc Ferrer; Óscar Soto-Angona; María Soler-Artigas; Pol Ibáñez; Christian Fadeuilhe; Raúl Felipe Palma-Álvarez; Raquefet Lidai; Sebastian Vargas-Cáceres; María Ángeles Torrecilla; Anna López; Josep Antoni Ramos-Quiroga
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-08-31       Impact factor: 3.731

Review 4.  Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.

Authors:  Justin Faden; Leslie Citrome
Journal:  Neuropsychiatr Dis Treat       Date:  2019-08-07       Impact factor: 2.570
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.